Headline

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Who We Are

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

What We Do

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Our Values

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Our Vision

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Management

Harel Gadot

Harel Gadot

PRESIDENT, CHIEF EXECUTIVE OFFICER AND
CHAIRMAN OF THE BOARD OF DIRECTORS

Mr. Gadot is a co-founder of Microbot Medical and has been serving as the CEO since its inception and the Chairman of the Board since 2013. He is also the Chairman of XACTRobotics Ltd., another promising medical robotics company, specializing in the field of needle steering for medical procedures such as biopsies. Show More
Until 2013, Mr. Gadot was a board member at ConTIPI Ltd. Which was acquired in 2012 by Kimberly Clark. Prior to founding Microbot Medical, Mr. Gadot served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, Middle East and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches. Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel. Mr. Gadot is a guest speaker for management and innovation courses at leading universities in the United States and Israel, and holds a Bachelor of Science (BS) from Siena College (USA) and a Master in Business Administration (MBA) from Manchester University (UK).

Eyal Morag

Eyal Morag, MD

CHIEF MEDICAL OFFICER

Dr. Eyal Morag will lead the development and execution of the clinical strategy of the Company’s technology platforms, including its current development of the Self-Cleaning Shunt (SCS) and LIBERTY products as well as its future pipeline. Dr. Morag has been a member of the Company’s Scientific Advisory Board since November 2017. Show More
Concurrently, Dr. Morag also serves as Chairman of Radiology at Assuta Ashdod Medical Center, Ashdod, Israel. Recently he served as the Regional Radiology Director at Mercy Health Partners Hospitals in Toledo, Ohio. He was a member of University Radiology Group (one of the largest private Radiology groups in the U.S.) where he headed the International Investment efforts for the Ventures division.
Dr. Morag has extensive international experience developing and establishing radiology-related businesses. During his fellowship, Dr. Morag co-founded InTek Technology, a medical device startup company. Later he founded Global Versa Radiology (GVR), an Israeli and U.S. based Teleradiology Company that has expanded reach to provide Interventional Radiology services to U.S. hospitals. Dr. Morag has served as GVR’s Chief Medical Officer and Vice-President.
Dr. Morag is certified by the American Board of Radiology and received his training at top medical institutions including: Boston University School of Medicine, MD; Brockton Hospital, an affiliate of Boston Medical Center & Boston University School of Medicine, Internship; Beth Israel Deaconess Medical Center & Harvard Medical School, Radiology Residency; Beth Israel Deaconess Medical Center & Harvard Medical School, Fellowship in Cardiovascular & Interventional Radiology.

Simon Sharon

Simon Sharon

CHIEF TECHNOLOGY OFFICER

Mr. Sharon is a seasoned medical device executive with over 30 years of industry experience. Prior to rejoining Microbot, Simon served as the Chief Technology Officer at MEDX Xelerator, an Israel-based medical device and digital health incubator with partners such as Boston Scientific Corporation and Intellectual Ventures. Show More
He was also the Chairman of the Scientific Board at XACT Robotics, a private Israeli company developing a novel platform robotic technology for needle steering in minimally invasive interventional procedures. Prior to this, Mr. Sharon held the position of Chief Operating Officer at Microbot Medical Ltd. before it became a publicly traded company. Prior to joining Microbot in 2013, Mr. Sharon was the Vice President of Research & Development with IceCure Medical, a TASE traded company developing a portfolio of cryogenic ablation systems. Prior to IceCure, he held roles of increasing responsibility at Rockwell Automation–Anorad Israel Ltd, a leading linear motor-based, precision positioning equipment manufacturer. Prior to Rockwell, Simon was the Research & Development Manager at Disc-O-Tech Medical Technologies Ltd., a private orthopedic venture that was acquired by Kyphon (currently part of Medtronic), and before this was the Research & Development Manager at CI Systems, a worldwide supplier of a wide range of electro-optical test and measurement equipment.

David Ben Naim

David Ben Naim

CHIEF FINANCIAL OFFICER

David Ben Naim is a CPA licensed in the State of Israel. During the past five years, Mr. Ben Naim has held the following positions: (i) from 2014 to the present, he has operated DBNFinancial, providing clients with full outsourcing financial and accounting services; (ii) from 2012 – 2014, he served as CFO of Insuline … Show More
Medical Ltd, a public company organized under the laws of the State of Israel listed on the Tel-Aviv Stock Exchange (TASE: INSL) focused on improving the performance of current insulin treatment methods. As CFO, Mr. Ben Naim reported to its CEO and worked closely with the Board and its various committees, planning and implementing the transition from the development stage into a TASE listed company and participating in the structure and raise of equity and debt capital, among other responsibilities; and (iii) from 2008 – 2011, Mr. Ben Naim served as CFO of Crow Technologies 1977 Ltd, public company traded on the OTCQB (CRWTF), with responsibilities for planning and implementation of corporate financial strategy, reporting to the CEO and working closely with the Board and its various committees.

Eran Cohen

Eran Cohen

SENIOR DIRECTOR BUSINESS DEVELOPMENT

Eran is an experienced executive and entrepreneur in the Life Sciences arena that co-founded and managed incubator-sponsored start-up companies in Israel. Prior to joining Microbot, Eran held senior Marketing & Business Development positions in Estar Medical (technologies and systems for the Regenerative … Show More
Medicine arena), Beleaf Herbal (herbal supplements for the treatment of obesity, erectile dysfunction, diabetes and a range of skin and hair conditions) and Accellta Ltd (transformational technology for mass production of human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for clinical and industrial applications). Eran serves as a business associate of Sama Brasil Comércio Internacional Ltda., a business development and trade company located in Brazil. Eran holds a BSc from the Hebrew University in Jerusalem and MBA from the Technion, Haifa.

Noa Ofer, PhD

Noa Ofer, PhD

INTELLECTUAL PROPERTY MANAGER

Dr. Noa Ofer oversees the development and expansion of Microbot Medical’s patent portfolio and innovation processes, directing all intellectual property aspects of the company. Dr. Ofer has vast experience in intellectual property counseling for a wide range of company stages, from start-up initial … Show More
stage companies to mature corporations, specializing in the medical device industry.
Prior to joining Microbot Medical, Dr. Ofer provided patent drafting and prosecuting services with some of the top Intellectual Property firms in the country, including the Medical Device Department of Ehrlich & Fenster IP firm. Dr. Ofer then proceeded to counsel in-house for the largest dental implants company in the country, MIS Implants Technologies LTD, where she worked closely with the legal and patent department of the US based top tier dental company, Dentsply Sirona. Throughout the years, Dr. Ofer has advised and educated a multitude of start-up groups, including through participation in a variety of hackathon events.
Dr. Ofer holds a Bachelor of Arts in Biology (BA), a Master in Medical Sciences (MSc) and a PhD in Nanotechnology, all from the Technion – Israel Institute of Technology. She was licensed as an Israeli patent attorney in 2016.

Scientific Advisory Board

Prof. Moshe Shoham

Prof. Moshe Shoham

SCIENTIFIC DIRECTOR

Prof Shoham is also the founder of Mazor Robotics Ltd, (Nasdaq: MZOR), a growing medical device company in the field of surgical robotics, recently sold to Medtronic for $1.6 Billion Prof. Shoham is the inventor of the company’s technologies and is a co-founder of the Company. Show More
Prof. Shoham is a worldwide acclaimed authority on the field of robotics and has been conducting research in this field for over 25 years with special focus on kinematics and dynamics of robots, sensor integration and medical applications. Prof Shoham is the head of the robotics lab at the Technion’s faculty of Mechanical Engineering. Prof. Shohan was formerly the director of the robotic laboratory of the Department of Mechanical Engineering at Columbia University in NY. Prof Shoham is also the founder of Mazor Surgical Technologies Ltd, (Nasdaq: MZOR), a growing medical device company in the field of surgical robotics. Prof Shoham has published over 150 conference and journal papers and he is the author of three books.

Ajay K. Wakhloo, MD, PhD, FAHA

Ajay K. Wakhloo, MD, PhD, FAHA

Dr Wakhloo is an internationally renowned Interventional Neuroradiologist. Dr. Wakhloo directs the Neurointerventional Radiology program at Beth Israel Lahey Health, Lahey Hospital and Medical Center and is Professor at Tufts University Medical School, Boston. Show More
He received his medical degree from the University of Mainz, Germany, where he also received his Ph.D. He completed a fellowship in interventional Neuroradiology at the University of Freiburg, Germany and an Endovascular Neurosurgery fellowship in the department of Neurosurgery at SUNY-Buffalo.
Dr. Wakhloo has been the principal investigator or co-investigator on numerous grants from the National Institutes of Health (NIH), American Heart Association (AHA), private foundations and industry. He has over 500 publications, presentations and abstracts, including 2 books on stroke treatment, and about 300 peer reviewed articles and book chapters. He has been the recipient of numerous scientific awards and honors, among others Whitaker Bioengineering Research Foundation Award, German Society of Neuroradiology and Society of Vascular Interventional Neurology Innovation Award. He was named a Fellow of the American Heart Association and the Stroke Council in 2009. He holds several US patents for neurovascular devices.
Dr. Wakhloo pioneered the field of flow diversion, the newest technology for the minimally invasive treatment of brain aneurysms. He has been the central figure in the commercial development of this technology, which in 2018 received from the U.S. Food and Drug Administration (FDA) a premarket approval (PMA). He was also the first to introduce and publish in 2008 the concept of using a retrievable stent to remove an embolus for the treatment of stroke which is currently the standard endovascular treatment for acute ischemic stroke. He has been a founder and has served as CEO and CMO of various medical device companies. Dr. Wakhloo has, throughout his career, been dedicated to teaching and mentoring faculty, fellows and residents from various disciplines as well as supervising doctoral students and serving as a research adviser to individuals throughout their research careers.

Giora Weisz, MD

Giora Weisz, MD

Dr. Weisz is an interventional cardiologist in NewYork-Presbyterian Columbia University Medical Center in New York city. He serves also as faculty of the Cardiovascular Research Foundation. Dr. Weisz graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel. Show More
He completed his cardiology fellowship training at the Carmel Medical Center-Technion School of Medicine in Haifa, Israel, and underwent advanced training in interventional cardiology at Lenox Hill Hospital and the Cardiovascular Research Foundation in New York City. Dr. Weisz is an internationally recognized researcher focused on innovative technologies in cardiovascular medicine. He has pioneered the use of novel robotic-enhanced coronary interventions, navigation and positioning technologies. Dr. Weisz has been the Principal Investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies for interventional cardiology device positioning and navigation and robotics, as well leading multicenter studies in interventional imaging and the combination of PCI with pharmacological anti-ischemic treatment. Dr. Weisz has published extensively in the most prestigious peer-review medical journals. He is an associate-director of TCT, which is the premier interventional cardiology conference, and is a regular faculty member for the most important international cardiovascular meetings.

Dmitry J. Rabkin, MD, PhD, FSIR

Dmitry J. Rabkin, MD, PhD, FSIR

Dr. Rabkin is a Vascular and Interventional Radiology Specialist, an Assistant Professor of Radiology at the Harvard Medical School and Assistant Chief of the Division of Interventional Radiology at the Brigham and Women’s Hospital. Previously, he was a Clinical Director and a Chief … Show More
of the Division of Interventional Radiology at the Beth Israel Deaconess Medical Center, HMS, where he completed his residency in Diagnostic Radiology and a fellowship in Vascular and Interventional Radiology. He graduated from the First Moscow Medical School. Based on his achievements and contributions to the specialty, Dr. Rabkin has been elected to Fellowship of the Society of Interventional Radiology. Dr. Rabkin has been recognized as a Castle Connolly Top Doctor and Boston Magazine Top Doctor since 2016 for his professional qualifications, reputation, and clinical skills in the field of Interventional Radiology.

Ziv Neeman, M.D.

Ziv Neeman, MD

Dr. Neeman specializes in Vascular & Interventional Radiology. He is the Director of the Diagnostic Imaging and Nuclear Medicine institute at Haemek Medical Center. Between 2017-2020, he was the Chairman of the Diagnostic Imaging Forum of the Ruth & Bruce Rapport Faculty of … Show More
Medicine (Technion- Israel Institute of technology, Haifa, Israel), where he also teaches medical students in the field of Diagnostic Imaging. His interests are Interventional Oncology & Interventional Radiology as well as Image-guided thermal ablation including radiofrequency, microwave, cryoablation and irreversible electroporation. He is a graduate of Ben Gurion University of the Negev Faculty of Health Sciences medical school. He has been published in multiple professional peer reviewed journals and has presented his work at multiple international scientific conferences worldwide. He is a member of the Israel Medical Association, the Israel Radiology Association and the Radiological Society of North America (RSNA).

Stephen B. Solomon, MD

Stephen B. Solomon, MD

Dr. Solomon is a board-certified radiologist with clinical expertise in Interventional Radiology, with a focus in Tumor Ablation (Radiofrequency Ablation and Cryoablation). He holds the Enid A. Haupt Chair in Clinical Investigation at Memorial Sloan Kettering where he is Chief of the Interventional Radiology Service.Show More
He leads a research lab that works to improve image-guided cancer interventions. He treats multiple cancer types and is interested in treating tumors with thermal ablation and catheter delivered therapies. Dr. Solomon received his undergraduate degree from Harvard and his MD from Yale School of Medicine. He completed his training at Yale-New Haven Hospital, The Johns Hopkins Hospital, and New York Hospital.

Gal Yaniv, M.D., Ph.D

Gal Yaniv, MD, PhD

Dr. Yaniv is Director of Endovascular Neurosurgery at Sheba Tel HaShomer City of Health and Chief Medical Officer of Aidoc Medical, a full body imaging AI software. He received his M.D. and Ph.D. in Apoptosis and Cardiology (both cum laude) from the Technion – Israel Institute of Technology. Show More
Dr. Yaniv completed his radiology residency at Sheba, Tel HaShomer hospital and a diagnostic neuroradiology fellowship at Yale School of Medicine and endovascular neurosurgery fellowship at Mount Sinai Hospital. In addition, Dr. Yaniv is a “Talpiot” alumni and participates in the “Talpiot Medical Leadership Program” at Tel HaShomer Hospital. He is the recipient of numerous awards and grants, has been published in numerous scientific publications focusing on basic science, radiology and public health and has presented at various scientific conferences worldwide.

Board of Directors

Harel Gadot

Harel Gadot

PRESIDENTCHIEF EXECUTIVE OFFICER AND
CHAIRMAN OF THE BOARD OF DIRECTORS

Mr. Gadot is a co-founder of Microbot Medical and has been serving as the CEO since its inception and the Chairman of the Board since 2013. He is also the Chairman of XACTRobotics Ltd., another promising medical robotics company, specializing in the field of needle steering for medical procedures such as biopsies. Show More
Until 2013, Mr. Gadot was a board member at ConTIPI Ltd. Which was acquired in 2012 by Kimberly Clark. Prior to founding Microbot Medical, Mr. Gadot served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, Middle East and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches. Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel. Mr. Gadot is a guest speaker for management and innovation courses at leading universities in the United States and Israel, and holds a Bachelor of Science (BS) from Siena College (USA) and a Master in Business Administration (MBA) from Manchester University (UK).

Yossi Bornstein

Yossi Bornstein

DIRECTOR AND CO-FOUNDER

Mr. Bornstein is a co-founder of Microbot Medical and has been a member of the Board of Directors since the inception of the company. Mr. Bornstein is the owner and President of Shizim Ltd., a life science holding group in Israel. Mr. Bornstein was the General Manager at Bristol-Myers Squibb (Israel) until 1992 when he joined the private sector. Show More
He is the founder of a number of privately held life-science companies including Pharmateam Ltd., which was sold in 2000. Mr. Bornstein was the Biotechnology Committee Chairman of USISTC (Unites States-Israel Science & Technology Commission) as well as a consultant for USISTF (Unites States-Israel Science & Technology Foundation). He is also the founder of ILSI-Israel Life Science Industry Organization and ITTN-Israel Tech Transfer Organization.

Tal Wenderow

Tal Wenderow

DIRECTOR

Mr. Wenderow is a Healthtech executive with a proven track record in bringing innovative & disruptive technologies to the healthcare market. Show More
Mr. Wenderow is currently the President & CEO of Vocalis Health a global technology leader in vocal biomarkers developing voice-enabled AI solutions to create proprietary vocal biomarkers for personalized healthcare screening and continuous remote monitoring of health by using a simple voice sample.
Prior to Vocalis Health Mr. Wenderow co-founded Corindus Vascular Robotics, acquired by Siemens Healthineers in 2019 for ~$1.1B; In his last position he served as the Executive Vice President of International & Business Development responsible for global sales and business partnerships of Corindus.
Mr. Wenderow holds a Bachelor of Science, Summa Cum Laude, in Mechanical Engineering from Technion in Israel and completed the Executive Program for Life Sciences at the Merage Foundation, Merage Business School, University of California, Irvine, CA, and has numerous patents issued based on his inventions.

Aileen Stockburger

Aileen Stockburger

DIRECTOR

Aileen Stockburger is a highly accomplished strategic planning and corporate transaction executive. She has managed and closed sizable worldwide mergers and acquisitions, licensing agreements, and divestitures, with cumulative purchase prices in excess of $70 Billion. Show More
Ms. Stockburger had a distinguished career at Johnson & Johnson, where she held numerous business development and finance roles and served in various business areas. Aileen also served on several internal boards at Johnson & Johnson, including: J&J Worldwide Orthopaedics Group, J&J Comprehensive Care Group, Johnson’s Baby Care Global Management Board, and J&J Development Corp.
Most recently, Aileen was Worldwide Vice President of Business Development for the DePuy Synthes Group of Johnson & Johnson. Prior to DePuy Synthes, Ms. Stockburger coordinated and led the Business Development efforts for the Medical Devices & Diagnostics companies of Johnson & Johnson. She also spent 10 years as the Vice President of Worldwide Mergers and Acquisitions for the Johnson & Johnson Consumer Group.
Before joining Johnson & Johnson, Aileen Stockburger spent several years at PriceWaterhouse Coopers, and earned her CPA certification. She received her MBA and BS from The Wharton School, University of Pennsylvania.

Martin J. Madden

Martin J. Madden

DIRECTOR

Martin J. Madden has a deep and broad background in medical device innovation and new product development. During his thirty-year tenure with Johnson & Johnson’s medical device organization, … Show More
Martin was an innovator and research leader for nearly every medical device business including Cardiology, Electrophysiology, Peripheral Vascular Surgery, General and Colorectal Surgery, Aesthetics, Orthopaedics, Sports Medicine, Spine, and Trauma. As an Executive and a Vice-President of Johnson & Johnson, Martin served on the management boards of Johnson & Johnson’s Global Surgery Group, Ethicon, Ethicon Endo-Surgery, DePuy-Synthes, and Cordis, with responsibility for research and development – inclusive of organic and licensed/acquired technology. Martin was also Chairman of J&J’s Medical Device Research Council, with responsibility for talent strategy and technology acceleration. Martin’s leadership experiences spanned internal start-ups, executing turn-around’s, and leading large portfolio and technology intensive research organizations. Martin serves on Board of Directors and is an advisor to numerous medical device start-ups. Martin has an MBA from Columbia University, an MS in Mechanical Engineering from Carnegie-Mellon University, and a BS in Mechanical Engineering from the University of Dayton.

Scott Burell

Scott Burell

DIRECTOR

Scott R. Burell. Since August 2018, Mr. Burell is the Chief Financial Officer of AIVITA Biomedical, Inc., an Irvine California-based immuno-oncology company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Show More
From November 2006, Mr. Burell served as Chief Financial Officer, Secretary and Treasurer of CombiMatrix Corporation (NASDAQ: CBMX), a publicly traded diagnostics laboratory, until it was acquired by Invitae Corporation (NYSE: NVTA) in November 2017. Prior to this, Mr. Burell had served as CombiMatrix’s Vice President of Finance and Controller since February 2001. From May 1999 to February 2001, Mr. Burell was the Controller for Network Commerce, Inc., (NASDAQ: SPNW), which was a publicly traded technology and information infrastructure company located in Seattle. Prior to this, Mr. Burell spent nine years with Arthur Andersen’s Audit and Business Advisory practice in Seattle. During his tenure in public accounting, Mr. Burell worked with many clients, both public and private, in the high-tech and healthcare markets, and was involved in numerous public offerings, spin-offs, mergers and acquisitions. Mr. Burell is also a board member of MER Telemanagement Solutions, Ltd., (NASDAQ: MTSL), an Israeli-based telecommunications company. Mr. Burell obtained his Washington state CPA license in 1992 (currently inactive). He holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University.

P. (Laxmin) Laximarain

P. (Laxmin) Laximarain

DIRECTOR

Mr. Laxminarain is a successful medical device executive with over 30 years’ experience and proven track record, most recently served as Worldwide President of Codman Neurosurgery (a Johnson & Johnson company), which was acquired by Integra LifeSciences Holdings Corporation … Show More
in October 2017 for approximately $1.045 billion. Mr. Laxminarain first joined Johnson & Johnson in 1986 where he held roles of increasing responsibility, including President of Codman Neurosurgery from 2006 to 2017. In addition, Mr. Laxminarain held senior medical device positions in India, Singapore and South Korea. Prior to Johnson & Johnson, he was a management consultant with AF Ferguson & Co., an audit and management consultancy business in India where he worked on strategy as well as execution related projects in a variety of industries. Mr. Laxminarain received an MBA from the Indian Institute of Management.